Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | FPI-2068 |
Trade Name | |
Synonyms | FPI2068|FPI 2068|[225Ac]-FPI-2068|225Ac-FPI-2068 |
Drug Descriptions |
FPI-2068 is a radioconjugate comprising a bispecific antibody that targets EGFR and MET linked to the radionuclide Actinium-225, which delivers radiation to tumor cells and potentially inhibits tumor growth (Mol Cancer Ther (2023) 22 (12_Supplement): A146). |
DrugClasses | EGFR Antibody 57 MET Antibody 29 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
FPI-2053 + FPI-2068 | FPI-2053 FPI-2068 | 0 | 1 |
FPI-2068 | FPI-2068 | 0 | 0 |